Research Topics
| Amanda C CohnSummaryAffiliation: Centers for Disease Control and Prevention Country: USA Publications
| Collaborators
|
Detail Information
Publications
Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)Amanda C Cohn
Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC, USA
MMWR Recomm Rep 62:1-28. 2013..Guidelines for antimicrobial chemoprophylaxis and for evaluation and management of suspected outbreaks of meningococcal disease also are provided...
Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal diseaseAmanda C Cohn
Meningitis and Vaccine Preventable Diseases Branch, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta Georgia 30333, USA
Clin Infect Dis 50:184-91. 2010..This report describes the epidemiologic features of meningococcal disease in the United States from January 1998 through December 2007, before and during implementation of adolescent quadrivalent meningococcal conjugate vaccination...- Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported bKatrina Kretsinger
Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, GA 30333, USA
MMWR Recomm Rep 55:1-37. 2006.... - Haemophilus influenzae type b disease and vaccine booster dose deferral, United States, 1998-2009Elizabeth C Briere
Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, MS C 25, Atlanta, GA 30333, USA
Pediatrics 130:414-20. 2012..In response to a limited vaccine supply that began in 2007, Hib booster doses were deferred for 18 months... - Early Impact of the US Tdap vaccination program on pertussis trendsTami H Skoff
Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mail Stop C 25, Atlanta, GA 30333, USA
Arch Pediatr Adolesc Med 166:344-9. 2012..To evaluate the impact of the adolescent Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine) vaccination program on pertussis trends in the United States... 
Haemophilus haemolyticus isolates causing clinical diseaseRaydel Anderson
Meningitis and Vaccine Preventable Disease Branch, Division of Bacterial Diseases, National Center for Infectious and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
J Clin Microbiol 50:2462-5. 2012..All cases had different symptoms and presentations. Our study suggests that a testing scheme that includes reliable PCR assays and standard microbiological methods should be used in order to improve H. haemolyticus identification...- Current epidemiology and trends in invasive Haemophilus influenzae disease--United States, 1989-2008Jessica R MacNeil
Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Clin Infect Dis 53:1230-6. 2011..With the introduction of Haemophilus influenzae serotype b (Hib) conjugate vaccines, there has been a dramatic reduction of Hib disease in young children and the epidemiological trends of invasive H. influenzae have shifted... - Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP)Karen R Broder
Epidemiology and Surveillance Division, National Immunization Program, CDC, USA
MMWR Recomm Rep 55:1-34. 2006.... - Early estimate of the effectiveness of quadrivalent meningococcal conjugate vaccineJessica R MacNeil
Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, GA, USA
Pediatr Infect Dis J 30:451-5. 2011..The Advisory Committee on Immunization Practices recommends MenACWYD for all adolescents 11 to 18 years of age and others at increased risk for meningococcal disease... - Haemophilus influenzae type b carriage among young children in metropolitan Atlanta in the context of vaccine shortage and booster dose deferralJennifer Dolan Thomas
Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Atlanta, Georgia 30329, USA
Clin Vaccine Immunol 18:2178-80. 2011..S. Hib vaccine shortage did not result in widespread Hib carriage in Atlanta, as the Hib carriage rate was found to be 0.3% (1/342). Hib colonization was significantly more common among males and day care attendees... - Meningococcal conjugate vaccination among adolescents aged 13-17 years, United States, 2007Peng Jun Lu
Immunization Services Division, National Center for Immunization and Respiratory Diseases, CCID, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Atlanta, GA 30333, USA
Vaccine 28:2350-5. 2010..In August 2007, vaccination recommendations were expanded for all adolescents 11-18 years... - Pertussis Pseudo-outbreak linked to specimens contaminated by Bordetella pertussis DNA From clinic surfacesSema Mandal
Epidemic Intelligence Service, Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, GA 30329, USA
Pediatrics 129:e424-30. 2012..We aimed to determine whether Bordetella pertussis was the causative agent and advise on control interventions... - Meningococcal disease: shifting epidemiology and genetic mechanisms that may contribute to serogroup C virulenceJessica R MacNeil
Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road Northeast, MS C 09, Atlanta, GA, 30333, USA
Curr Infect Dis Rep 13:374-9. 2011..This review highlights the current epidemiology of meningococcal disease in Europe and United States, as well as genetic mechanisms that may affect virulence of serogroup C strains and effectiveness of new vaccines... - Emergence of ciprofloxacin-resistant Neisseria meningitidis in North AmericaHenry M Wu
Office of Workforce and Career Development, and the Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
N Engl J Med 360:886-92. 2009..Ciprofloxacin-resistant N. meningitidis has emerged in North America... - Adolescent immunizations and other clinical preventive services: a needle and a hook?Karen R Broder
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Pediatrics 121:S25-34. 2008..Studies are needed to evaluate the effect of new immunizations on adolescent preventive health care visits, delivery of clinical preventive services, and health outcomes... - Immunizations in the United States: a rite of passageAmanda C Cohn
National Immunization Program, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
Pediatr Clin North Am 52:669-93, v. 2005.... - Effects of a nationwide Hib vaccine shortage on vaccination coverage in the United StatesTammy A Santibanez
Centers for Disease Control and Prevention, Clifton Road, NE, Atlanta, GA 30333, USA
Vaccine 30:941-7. 2012....